We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
HF Sinclair
DINO
$16.3B
| $1.34M | ﹤0.01% |
29,106
-576,643
| -95% | -$29.7M |
|
2002
Clarivate
CLVT
$1.25B
| $1.34M | ﹤0.01% |
400,480
-4,482,113
| -92% | -$15.9M |
|
2003
MYR Group
MYRG
$5.1B
| $1.33M | ﹤0.01% |
6,090
-13,344
| -69% | -$2.9M |
|
|
CBIO
2004
Crescent Biopharma
CBIO
$618M
| $1.32M | ﹤0.01% |
+111,715
| New | +$1.42M |
|
2005
PUT
Twilio
TWLO
$38.3B
| $1.32M | ﹤0.01% |
+9,300
| New | +$1.15M |
|
2006
Corsair Gaming
CRSR
$1.45B
| $1.32M | ﹤0.01% |
+222,569
| New | +$1.55M |
|
2007
FNB Corp
FNB
$6.88B
| $1.32M | ﹤0.01% |
76,915
+22,131
| +40% | +$362K |
|
2008
East-West Bancorp
EWBC
$18.6B
| $1.31M | ﹤0.01% |
11,660
-3,437
| -23% | -$365K |
|
2009
PUT
T. Rowe Price
TROW
$23.7B
| $1.31M | ﹤0.01% |
+12,800
| New | +$1.32M |
|
|
NPKI
2010
NPK International
NPKI
$1.18B
| $1.31M | ﹤0.01% |
+109,824
| New | +$1.34M |
|
2011
Cadence Design Systems
CDNS
$89.2B
| $1.3M | ﹤0.01% |
4,170
-22,898
| -85% | -$7.47M |
|
2012
CALL
Ross Stores
ROST
$78.6B
| $1.3M | ﹤0.01% |
+7,200
| New | +$1.2M |
|
2013
Prosperity Bancshares
PB
$8.97B
| $1.29M | ﹤0.01% |
18,714
+4,752
| +34% | +$321K |
|
2014
W.R. Berkley
WRB
$26.2B
| $1.29M | ﹤0.01% |
18,371
-1,063,591
| -98% | -$78.4M |
|
2015
CALL
Rubrik
RBRK
$21.6B
| $1.28M | ﹤0.01% |
+16,800
| New | +$1.29M |
|
|
GTY
2016
Getty Realty Corp
GTY
$2.05B
| $1.28M | ﹤0.01% |
46,913
+25,077
| +115% | +$693K |
|
2017
CALL
CME Group
CME
$96.1B
| $1.28M | ﹤0.01% |
4,700
+2,000
| +74% | +$543K |
|
|
MPT
2018
CALL
Medical Properties Trust
MPT
$2.51B
| $1.28M | ﹤0.01% |
256,500
+71,200
| +38% | +$371K |
|
2019
PUT
Linde
LIN
$220B
| $1.28M | ﹤0.01% |
3,000
-13,900
| -82% | -$5.95M |
|
2020
CALL
IBM
IBM
$223B
| $1.27M | ﹤0.01% |
4,300
-2,100
| -33% | -$629K |
|
|
MPT
2021
PUT
Medical Properties Trust
MPT
$2.51B
| $1.27M | ﹤0.01% |
254,100
+58,900
| +30% | +$307K |
|
2022
Maplebear
CART
$11.6B
| $1.27M | ﹤0.01% |
28,232
+12,062
| +75% | +$494K |
|
2023
Phillips 66
PSX
$92.8B
| $1.27M | ﹤0.01% |
9,830
-3,417
| -26% | -$460K |
|
2024
CALL
Live Nation Entertainment
LYV
$43.3B
| $1.27M | ﹤0.01% |
8,900
-106,600
| -92% | -$15.3M |
|
2025
DoorDash
DASH
$93.7B
| $1.27M | ﹤0.01% |
5,594
-398,785
| -99% | -$93.5M |
|
Similar funds
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.